SYNLOGIC, INC. Current Assets
SYNLOGIC, INC. (SYBX) had Current Assets of $13.43 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $13.43M.
- 2026-03-31: Assets, Current $14.56M.
- 2025-12-31: Assets, Current $15.40M.
- 2025-09-30: Assets, Current $16.50M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $13.43M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $14.56M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $15.40M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $16.50M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $17.32M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $17.92M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $19.78M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $20.70M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $21.57M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $34.95M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $49.91M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $37.78M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $49.56M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $62.36M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $79.78M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $97.46M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $111.10M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $124.42M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $133.31M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $156.60M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $122.68M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $101.20M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $106.85M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $110.64M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $122.23M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $127.42M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $133.25M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $131.32M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $162.90M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $113.79M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $124.34M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $136.00M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $145.32M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $127.86M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $88.59M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $98.23M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $48.11M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $58.15M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $16.06M 10-K · filed 2018-03-20 | $61.38M 10-K · filed 2017-03-15 |
| 2016-09-30 | $67.08M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $73.50M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $81.61M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $90.54M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $36.10M 10-Q · filed 2015-11-13 | |
| 2014-12-31 | $9.62M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |